Novo Nordisk Invest 4 A/S: Financial statements 2018
CVR: 31853923
Novo Nordisk Invest 4 A/S (CVR 31853923) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK 189,000 compared with DKK -775,000 the year before. Equity amounted to DKK 9,315,000. The solvency ratio was 91.4%.
- Profit/Loss
- 189,000 kr.
- Equity
- 9,315,000 kr.
- Total Assets
- 10,188,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | 189 t. | 9.3 mio. | - |
| 2017 | - | - | -775 t. | 9.1 mio. | - |
| 2016 | - | - | -407 t. | 9.9 mio. | - |
| 2015 | 219.3 mio. | - | 803 t. | 10.3 mio. | - |
| 2013 | 181.8 mio. | - | -214 t. | 5.7 mio. | - |
Keep an eye on Novo Nordisk Invest 4 A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of October 1, 2018, Tomas Haagen has joined the board of directors of Novo Nordisk Invest 4 A/S.
As of October 1, 2018, Ole Falvig Ramsby has left the board of directors of Novo Nordisk Invest 4 A/S.
Novo Nordisk Invest 4 A/S has published its annual report for 2017. The net result was DKK -775,000.
As of April 25, 2018, Karsten Munk Knudsen has joined the board of directors of Novo Nordisk Invest 4 A/S.
As of April 25, 2018, Jesper Brandgaard has left the board of directors of Novo Nordisk Invest 4 A/S.
As of April 25, 2018, Peter Bøggild is registered as director of Novo Nordisk Invest 4 A/S.
As of April 25, 2018, Karsten Munk Knudsen has stepped down as director of Novo Nordisk Invest 4 A/S.
About Novo Nordisk Invest 4 A/S
Novo Nordisk Invest 4 A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 2008. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named STENO DIABETES CENTER A/S. The management consists of Anders Rytter Mikkelsen. The company is owned by NOVO NORDISK A/S. The company has 0 employees. In 2025, the company reported a gross profit of DKK -64,000 and a net result of DKK -23,000 compared with DKK 7,000 the year before. Equity amounted to DKK 1,772,000.
